Financial Planning News
Wed, 7 Aug 2013
Read the rest of this article on Financial Planning News
Morningstar CEO of the Year finalist John Martin's smart capital-allocation decisions have helped drive a 100-fold increase in this biopharmaceutical's stock since he took over in 1996.
Five stats from the market and the stories behind them. This week: a shakeup in J.C. Penney's board, the DOJ seeks to ground a major airline merger , and BlackBerry mulls a sale.
The Medalist-rated Merger and Arbitrage funds both invest in publicly announced merger transactions, but each has its own special tilt.
This merger -arbitrage fund has little correlation to the broader equity and fixed-income markets and has a very low expense ratio.
©2017 Morningstar Advisor. All right reserved.